Omeros Corp. (OMER)
17.89
-0.56
(-3.04%)
USD |
NASDAQ |
Sep 18, 16:00
17.89
0.00 (0.00%)
After-Hours: 20:00
Omeros Enterprise Value : 1.495B for Sept. 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.495B |
| September 16, 2026 | 1.415B |
| September 15, 2026 | 1.403B |
| September 14, 2026 | 1.424B |
| September 11, 2026 | 1.483B |
| September 10, 2026 | 1.505B |
| September 09, 2026 | 1.563B |
| September 08, 2026 | 1.543B |
| September 04, 2026 | 1.531B |
| September 03, 2026 | 1.543B |
| September 02, 2026 | 1.524B |
| September 01, 2026 | 1.517B |
| August 31, 2026 | 1.519B |
| August 28, 2026 | 1.506B |
| August 27, 2026 | 1.553B |
| August 26, 2026 | 1.478B |
| August 25, 2026 | 1.555B |
| August 24, 2026 | 1.558B |
| August 21, 2026 | 1.554B |
| August 20, 2026 | 1.508B |
| August 19, 2026 | 1.491B |
| August 18, 2026 | 1.404B |
| August 17, 2026 | 1.416B |
| August 14, 2026 | 1.404B |
| August 13, 2026 | 1.416B |
| Date | Value |
|---|---|
| August 12, 2026 | 1.153B |
| August 11, 2026 | 1.145B |
| August 10, 2026 | 1.147B |
| August 07, 2026 | 1.120B |
| August 06, 2026 | 1.113B |
| August 05, 2026 | 1.077B |
| August 04, 2026 | 1.098B |
| August 03, 2026 | 1.070B |
| July 31, 2026 | 1.018B |
| July 30, 2026 | 1.025B |
| July 29, 2026 | 1.006B |
| July 28, 2026 | 978.07M |
| July 27, 2026 | 982.39M |
| July 24, 2026 | 870.66M |
| July 23, 2026 | 905.98M |
| July 22, 2026 | 874.26M |
| July 21, 2026 | 851.92M |
| July 20, 2026 | 859.12M |
| July 17, 2026 | 863.45M |
| July 16, 2026 | 829.57M |
| July 15, 2026 | 912.47M |
| July 14, 2026 | 921.84M |
| July 13, 2026 | 886.52M |
| July 10, 2026 | 905.98M |
| July 09, 2026 | 905.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.131T |
| Talphera, Inc. | 50.15M |
| Hyperion DeFi, Inc. | 52.37M |
| ANI Pharmaceuticals, Inc. | 1.967B |
| Corcept Therapeutics, Inc. | 12.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.637M |
| Revenue (Quarterly) | 28.53M |
| Total Expenses (Quarterly) | 21.89M |
| EPS Diluted (Quarterly) | 0.1476 |
| Gross Profit Margin (Quarterly) | 96.50% |
| Profit Margin (Quarterly) | 23.26% |
| Earnings Yield | 8.04% |
| Normalized Earnings Yield | 9.423 |